Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia
Crossref DOI link: https://doi.org/10.1007/s12032-015-0682-z
Published Online: 2015-08-28
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freyer, Gilles
Kalinka-Warzocha, Ewa
Syrigos, Konstantinos
Marinca, Mihai
Tonini, Giuseppe
Ng, Say Liang
Wong, Zee Wan
Salar, Antonio
Steger, Guenther
Abdelsalam, Mahmoud
DeCosta, Lucy
Szabo, Zsolt
Funding for this research was provided by:
Amgen
Text and Data Mining valid from 2015-08-28